Pfizer Limited — Board Meeting, 13-08-2025: Outcome of Board Meeting

Pfizer Limited has announced a board meeting outcome: approval of financial results for the quarter ended June 30, 2025. The company's revenue from operations rose to ₹603.05 Cr from ₹562.86 Cr in the same period last year. Net profit significantly increased to ₹191.75 Cr compared to ₹150.71 Cr year-on-year. This strong performance led to an earnings per share (EPS) of ₹41.91. Pfizer continues to operate solely in the Pharmaceuticals segment, delivering robust growth.